ZETONNA®

Hold Company

COVIS

Learn More

Dosage and Administration

AEROSOL, METERED;NASAL

Specification

0.037MG/INH

Indication

ZETONNA® is used in seasonal allergic rhinitis and perennial allergic rhinitis.

Use

Instructions for Use

API

CICLESONIDE

API Structure

We Supply

CICLESONIDE

Note:

Facility GMP

null

Note:

null

null

Note:

null

Drug Patent

Patent No	Expiration Date
8371292	2028/2/1

API Patent

Patent No	Expiration Date
8371292	2028/2/1

Note: The patent information provided herein is derived solely from publicly available data in the FDA Orange Book (or other cited sources) and is presented for general informational purposes only. Actual patent status may vary based on jurisdictional rulings, regulatory extensions or other factors.